News
BIO-B
294.23
0.00%
0.00
Weekly Report: what happened at BIO B last week (0715-0719)?
Weekly Report · 4d ago
Weekly Report: what happened at BIO B last week (0708-0712)?
Weekly Report · 07/15 09:05
Weekly Report: what happened at BIO B last week (0701-0705)?
Weekly Report · 07/08 09:05
Weekly Report: what happened at BIO B last week (0624-0628)?
Weekly Report · 07/01 09:05
Weekly Report: what happened at BIO B last week (0617-0621)?
Weekly Report · 06/24 09:05
Weekly Report: what happened at BIO B last week (0610-0614)?
Weekly Report · 06/17 09:05
Weekly Report: what happened at BIO B last week (0603-0607)?
Weekly Report · 06/10 09:05
Weekly Report: what happened at BIO B last week (0527-0531)?
Weekly Report · 06/03 09:05
Weekly Report: what happened at BIO B last week (0520-0524)?
Weekly Report · 05/27 09:05
Weekly Report: what happened at BIO B last week (0513-0517)?
Weekly Report · 05/20 09:05
Weekly Report: what happened at BIO B last week (0506-0510)?
Weekly Report · 05/13 09:05
Bio-Rad Laboratories, Inc. Form 10-Q for the Quarter Ended March 31, 2024
Press release · 05/10 01:48
Weekly Report: what happened at BIO B last week (0429-0503)?
Weekly Report · 05/06 09:05
Weekly Report: what happened at BIO B last week (0422-0426)?
Weekly Report · 04/29 09:05
Bio Rad Laborato: Current report
Press release · 04/27 09:53
BIO-RAD LABORATORIES INC REPORTS 8.99% PASSIVE STAKE IN ONCOCYTE CORP AS OF APRIL 15 - SEC FILING
Reuters · 04/22 17:31
Weekly Report: what happened at BIO B last week (0415-0419)?
Weekly Report · 04/22 09:05
Weekly Report: what happened at BIO B last week (0408-0412)?
Weekly Report · 04/15 09:05
BUZZ-OncoCyte jumps on partnership with Bio-Rad
OncoCyte shares rise 93.3% to $5.73 in extended trading. Company announces partnership with Bio-Rad for blood-based organ transplantation monitoring test GraftAssure. Shares of diagnostics company up 18.6% year-to-date.
Reuters · 04/11 22:09
ONCOCYTE CORP - BIO-RAD EXPECTS TO MAKE EQUITY INVESTMENT IN SUPPORT OF DEAL
Reuters · 04/11 21:30
More
Webull provides a variety of real-time BIO-B stock news. You can receive the latest news about Bio Rad Laborato through multiple platforms. This information may help you make smarter investment decisions.
About BIO-B
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.